Blog

New Resource and Request for Input on NIH Policy for Data Management and Sharing

As part of the push to implement the NIH Data Management and Sharing Policy on January 25, 2023, the NIH has released Informed Consent for...

Read The Article

FDA Announces New Accelerating Rare Disease Cures (ARC) Program

FDA’s Center for Drug Evaluation and Research (CDER) has launched its new Accelerating Rare Disease Cures (ARC) Program to accelerate the development of safe and...

Read The Article

New Features and Fixes to ClinicalTrials.gov Beta

In December of 2021, the National Institutes of Health (NIH) released the ClinicalTrials.gov Beta to improve the interface and search functions as well as a...

Read The Article

What CITI Program is Reading – May 10, 2022

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...

Read The Article

CITI Program’s May 2022 Media Playlist – Part 1

CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for...

Read The Article

National Women’s Health Week 2022

Led by the U.S. Department of Health and Human Services’ Office on Women’s Health (OWH), National Women’s Health Week from May 8–14, 2022 is an...

Read The Article

Mental Health Awareness Month 2022

Started in 1949, by Mental Health America (MHA), Mental Health Awareness Month is a time to raise awareness and educate the public about mental illness,...

Read The Article

What CITI Program is Reading – May 3, 2022

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...

Read The Article

FDA Releases Guidance on Drug Products That Contain Nanomaterials

The FDA has released the guidance document “Drug Products, Including Biological Products, that Contain Nanomaterials – Guidance for Industry.” It finalizes the draft guidance issued...

Read The Article

FDA Issues Fourth Notice of Noncompliance with ClinicalTrials.gov Requirements

In April of 2021, the FDA issued its first Notice of Noncompliance to a company failing to submit required summary results information to ClinicalTrials.gov. This...

Read The Article